- Home
- DNLI vs NWN Comparison
DNLI vs NWN Comparison
Compare DNLI & NWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- NWN
- Stock Information
- Founded
- DNLI 2013
- NWN 1859
- Country
- DNLI United States
- NWN United States
- Employees
- DNLI N/A
- NWN N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- NWN Oil/Gas Transmission
- Sector
- DNLI Health Care
- NWN Utilities
- Exchange
- DNLI Nasdaq
- NWN Nasdaq
- Market Cap
- DNLI 1.9B
- NWN 1.7B
- IPO Year
- DNLI 2017
- NWN N/A
- Fundamental
- Price
- DNLI $13.21
- NWN $41.00
- Analyst Decision
- DNLI Strong Buy
- NWN Strong Buy
- Analyst Count
- DNLI 15
- NWN 3
- Target Price
- DNLI $33.85
- NWN $44.67
- AVG Volume (30 Days)
- DNLI 1.3M
- NWN 289.4K
- Earning Date
- DNLI 05-06-2025
- NWN 05-06-2025
- Dividend Yield
- DNLI N/A
- NWN 4.78%
- EPS Growth
- DNLI N/A
- NWN 11.40
- EPS
- DNLI N/A
- NWN 2.61
- Revenue
- DNLI N/A
- NWN $1,213,808,000.00
- Revenue This Year
- DNLI N/A
- NWN $18.65
- Revenue Next Year
- DNLI $256.73
- NWN $8.41
- P/E Ratio
- DNLI N/A
- NWN $15.73
- Revenue Growth
- DNLI N/A
- NWN 3.88
- 52 Week Low
- DNLI $10.57
- NWN $34.82
- 52 Week High
- DNLI $33.33
- NWN $44.38
- Technical
- Relative Strength Index (RSI)
- DNLI 44.46
- NWN 42.41
- Support Level
- DNLI $12.86
- NWN $40.66
- Resistance Level
- DNLI $13.77
- NWN $41.10
- Average True Range (ATR)
- DNLI 0.72
- NWN 0.71
- MACD
- DNLI -0.08
- NWN -0.05
- Stochastic Oscillator
- DNLI 32.29
- NWN 57.39
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About NWN Northwest Natural Holding Company
Northwest Natural Holding Co is a public natural gas service supplier operating in the U.S. Pacific Northwest. Its subsidiary, NW Natural, operates through the natural gas distribution segment, which purchases and distributes natural gas through which operates in Oregon and southwest Washington. The company operates in one reportable business segment, which is NW Natural's local gas distribution business and is referred to as the NGD segment. The company generates its revenue from residential, commercial, and industrial customers, the majority of which are in Oregon. Residential and commercial customers account for the vast majority of profitability.